Tuberculosis (TB) is the world’s deadliest infectious disease, killing 1.25 million people in 2023.MTBVAC is a promising vaccine candidate being evaluated in the IMAGINE trial, a large-scale safety and efficacy trial evaluating the prevention of TB dis…
Continue ReadingThe vaccine candidate is being evaluated in a ring vaccination trial as part of a comprehensive public health response NEW YORK CITY, NY / ACCESS Newswire / February 3, 2025 / The first participants have been vaccinated with an investigational Ebola Su…
Continue ReadingAgreement signed to establish collaboration between IAVI and IPDNew partnership aims to accelerate vaccine development and manufacturing for priority pathogens that disproportionately impact AfricaAligns with Africa’s regional vaccine manufac…
Continue ReadingBespoke global outsourcing firm proudly enters African market; company to create hundreds of new jobs ACCRA, GHANA / ACCESSWIRE / October 24, 2024 / Ubiquity Global Services, a leading provider of customer experience, risk, compliance, and back office operations, opened its doors at a new site in Accra, Ghana earlier this month. The state-of-the-art center […]
Continue ReadingA Selling Exhibition of Multidisciplinary Works by 8 Global ArtistsLONDON, ENGLAND / ACCESSWIRE / September 25, 2024 / HOFA Gallery and PhillipsX announce the launch of ‘SPACES’, the inaugural selling exhibition in HOFA’s new curated digital realities …
Continue ReadingNEW YORK, NY / ACCESSWIRE / September 25, 2024 / The Africa Centres for Disease Control and Prevention (Africa CDC) and IAVI, a nonprofit scientific research organization, have signed a Memorandum of Understanding (MoU) to enhance the continent’s disea…
Continue Reading